FEMALE SEXUAL DYSFUNCTION
Female sexual dysfunction affect up to 43% of women causing a "distress" or a psychological strain for the patients. A variety of chronic diseases in addition to menopause and different drugs represents the risk factors to a female sexual dysfunction. Since 2015 the FDA has approved Fliban...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2016-06-01
|
| Series: | Акушерство, гинекология и репродукция |
| Subjects: | |
| Online Access: | https://www.gynecology.su/jour/article/view/185 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849395281268834304 |
|---|---|
| author | C. DADAK M. BAYERLE-EDE |
| author_facet | C. DADAK M. BAYERLE-EDE |
| author_sort | C. DADAK |
| collection | DOAJ |
| description | Female sexual dysfunction affect up to 43% of women causing a "distress" or a psychological strain for the patients. A variety of chronic diseases in addition to menopause and different drugs represents the risk factors to a female sexual dysfunction. Since 2015 the FDA has approved Flibanserin for the treatment of female libido although several other drugs have been proven efficacious. |
| format | Article |
| id | doaj-art-e04d76fcee654ab5ba9d70153d145a7b |
| institution | Kabale University |
| issn | 2313-7347 2500-3194 |
| language | Russian |
| publishDate | 2016-06-01 |
| publisher | IRBIS LLC |
| record_format | Article |
| series | Акушерство, гинекология и репродукция |
| spelling | doaj-art-e04d76fcee654ab5ba9d70153d145a7b2025-08-20T03:39:40ZrusIRBIS LLCАкушерство, гинекология и репродукция2313-73472500-31942016-06-0194868810.17749/2070-4968.2015.9.4.086-088183FEMALE SEXUAL DYSFUNCTIONC. DADAK0M. BAYERLE-EDE1University Clinic of obstetrics and gynecology, Vienna, AustriaMedical University of Vienna, AustriaFemale sexual dysfunction affect up to 43% of women causing a "distress" or a psychological strain for the patients. A variety of chronic diseases in addition to menopause and different drugs represents the risk factors to a female sexual dysfunction. Since 2015 the FDA has approved Flibanserin for the treatment of female libido although several other drugs have been proven efficacious.https://www.gynecology.su/jour/article/view/185female sexual dysfunctionogasms disordersflibanserin |
| spellingShingle | C. DADAK M. BAYERLE-EDE FEMALE SEXUAL DYSFUNCTION Акушерство, гинекология и репродукция female sexual dysfunction ogasms disorders flibanserin |
| title | FEMALE SEXUAL DYSFUNCTION |
| title_full | FEMALE SEXUAL DYSFUNCTION |
| title_fullStr | FEMALE SEXUAL DYSFUNCTION |
| title_full_unstemmed | FEMALE SEXUAL DYSFUNCTION |
| title_short | FEMALE SEXUAL DYSFUNCTION |
| title_sort | female sexual dysfunction |
| topic | female sexual dysfunction ogasms disorders flibanserin |
| url | https://www.gynecology.su/jour/article/view/185 |
| work_keys_str_mv | AT cdadak femalesexualdysfunction AT mbayerleede femalesexualdysfunction |